Will Continuous Glucose Monitoring Metrics Replace Hemoglobin A1c in Assessing the Risk of Retinopathy (and Other Complications) in Patients with Type 2 Diabetes?
Clinical Diabetology · 2024
DOI: 10.5603/cd.101353 ↗At a glance
Journal article in Clinical Diabetology, 2024. Written by Magdalena Walicka and 1 co-authors.
Topics: Diabetes mellitus
Abstract (original language)
Clinical Diabetology is a bimonthly, open access journal of scientific and educational profile, which was created by combining the scientific assumptions of Experimental and Clinical Diabetology (Diabetologia Doświadczalna i Kliniczna)
Cite
APA
Walicka, M., & Franek, E. (2024). Will Continuous Glucose Monitoring Metrics Replace Hemoglobin A1c in Assessing the Risk of Retinopathy (and Other Complications) in Patients with Type 2 Diabetes?. Clinical Diabetology. https://doi.org/10.5603/cd.101353
Vancouver
Walicka M, Franek E. Will Continuous Glucose Monitoring Metrics Replace Hemoglobin A1c in Assessing the Risk of Retinopathy (and Other Complications) in Patients with Type 2 Diabetes?. Clinical Diabetology. 2024. doi:10.5603/cd.101353
BibTeX
@article{Walicka2024,
author = {Walicka, Magdalena and Franek, Edward},
title = {Will Continuous Glucose Monitoring Metrics Replace Hemoglobin A1c in Assessing the Risk of Retinopathy (and Other Complications) in Patients with Type 2 Diabetes?},
journal = {Clinical Diabetology},
year = {2024},
doi = {10.5603/cd.101353}
}
EUVIMED